Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · IEX Real-Time Price · USD
16.59
+1.19 (7.73%)
At close: May 17, 2024, 4:00 PM
16.84
+0.25 (1.51%)
After-hours: May 17, 2024, 6:10 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $983.19 million as of May 17, 2024. Its market cap has increased by 103.56% in one year.
Market Cap
983.19M
Enterprise Value
767.45M
1-Year Change
103.56%
Ranking
Category
Stock Price
$16.59
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.10M to $983.19M, an increase of 39.64%. That is a compound annual growth rate of 9.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 815.40M | 7.73% |
| May 16, 2024 | 756.90M | -3.15% |
| May 15, 2024 | 781.50M | 6.36% |
| May 14, 2024 | 734.80M | 7.24% |
| May 13, 2024 | 685.20M | 3.19% |
| May 10, 2024 | 664.00M | -3.16% |
| May 9, 2024 | 685.70M | -0.20% |
| May 8, 2024 | 687.10M | -1.28% |
| May 7, 2024 | 696.00M | 7.11% |
| May 6, 2024 | 649.80M | 3.45% |
| May 3, 2024 | 628.10M | 0.38% |
| May 2, 2024 | 625.70M | -2.68% |
| May 1, 2024 | 642.90M | 8.82% |
| Apr 30, 2024 | 590.80M | -3.61% |
| Apr 29, 2024 | 612.90M | 0.89% |
| Apr 26, 2024 | 607.50M | - |
| Apr 25, 2024 | 607.50M | -10.11% |
| Apr 24, 2024 | 675.80M | -2.69% |
| Apr 23, 2024 | 694.50M | 4.04% |
| Apr 22, 2024 | 667.50M | -0.07% |
| Apr 19, 2024 | 668.00M | -5.88% |
| Apr 18, 2024 | 709.70M | 2.56% |
| Apr 17, 2024 | 692.00M | -3.90% |
| Apr 16, 2024 | 720.10M | -5.24% |
| Apr 15, 2024 | 759.90M | -7.64% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ironwood Pharmaceuticals | 1.03B |
| Simulations Plus | 1.02B |
| BioLife Solutions | 1.01B |
| Innoviva | 997.87M |
| Perspective Therapeutics | 993.09M |
| Standard BioTools | 980.61M |
| Artivion | 977.42M |
| Scholar Rock Holding | 974.60M |